Omeros Corporation — Quarterly Financial Statements (NASDAQ:OMER) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Market Capitalization 798.48 M
Employee 202
Founded 1994
CEO N/A
Website www.omeros.com
Headquarter Washington, United States
FIGI BBG000JLP4B4
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

798.48 M Market capitalization

Price to earnings ratio

-2.04

Price to sales ratio

177.12

Dividends per share

—

Dividend yield %

—

Haberler

Omeros hisseleri ilk YARTEMLEA ticari sevkiyatlarının başlamasıyla yükseldi

Omeros stock rises as first commercial YARTEMLEA shipments begin

Omeros begins commercial distribution of TA-TMA treatment Yartemlea

Omeros VP Borges sells $750k in shares

Omeros Corporation (OMER) Discusses FDA Approval and Commercialization Plans for YARTEMLEA in TA-TMA Treatment Transcript

Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA

Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (NASDAQ:OMER)

Biohaven, Omeros And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Andersen Group (NYSE:ANDG), Biohaven (NYSE:BHVN)

Why Davis Commodities Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AlphaTON Capital (NASDAQ:ATON), Biohaven (NYSE:BHVN)

NKE, OMER, MU, INTC, DVAX: 5 Trending Stocks Today - Nike (NYSE:NKE)

Omeros: Stock Pops On Yartemlea Approval, Longer-Term Upside Likely (NASDAQ:OMER)

Micron Tech and Nike among market cap stock movers on Wednesday